ReachMD
ReachMD CME
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.
Husk at besøge podcastens hjemmeside og støtte skaberen: reachmd.com
Hvor kan du lytte?
Podcasts i appen Replaio Radio Kommer snartPodcasts kommer snart til appen. Installer nu, og vær den første til at se en helt ny tilgang til podcasts
Episoder
Managing Adverse Events Associated With Menin Inhibitors 25.07.2025 4:15
CME credits: 1.00 Valid until: 25-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/managing-adverse-events-associated-with-menin-inhibitors/36182/ This online CME activity explores the evolving treatment landscape of acute myeloid leukemia (AML), emphasizing the importance of molecular profiling and risk stratification to guide precision therapy. Experts discuss guideline-based st...
Incorporating Guideline-Recommended Targeted Therapies Into R/R AML Management 25.07.2025 5:00
CME credits: 1.00 Valid until: 25-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/incorporating-guideline-recommended-targeted-therapies-into-rr-aml-management/36181/ This online CME activity explores the evolving treatment landscape of acute myeloid leukemia (AML), emphasizing the importance of molecular profiling and risk stratification to guide precision therapy. Experts discu...
Clinical Evidence on Monotherapy With Menin Inhibitors in R/R AML 25.07.2025 4:45
CME credits: 1.00 Valid until: 25-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/clinical-evidence-on-monotherapy-with-menin-inhibitors-in-rr-aml/36180/ This online CME activity explores the evolving treatment landscape of acute myeloid leukemia (AML), emphasizing the importance of molecular profiling and risk stratification to guide precision therapy. Experts discuss guideline-...
Menin Inhibitors: Biologic and Clinical Rationale 25.07.2025 5:00
CME credits: 1.00 Valid until: 25-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/menin-inhibitors-biologic-and-clinical-rationale/36179/ This online CME activity explores the evolving treatment landscape of acute myeloid leukemia (AML), emphasizing the importance of molecular profiling and risk stratification to guide precision therapy. Experts discuss guideline-based strategies...
Molecular Profiling as a Cornerstone of Precision AML Therapy 25.07.2025 4:30
CME credits: 1.00 Valid until: 25-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/molecular-profiling-as-a-cornerstone-of-precision-aml-therapy/36178/ This online CME activity explores the evolving treatment landscape of acute myeloid leukemia (AML), emphasizing the importance of molecular profiling and risk stratification to guide precision therapy. Experts discuss guideline-bas...
Stratifying Risk to Guide Therapy in R/R AML 25.07.2025 5:00
CME credits: 1.00 Valid until: 25-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/stratifying-risk-to-guide-therapy-in-rr-aml/36177/ This online CME activity explores the evolving treatment landscape of acute myeloid leukemia (AML), emphasizing the importance of molecular profiling and risk stratification to guide precision therapy. Experts discuss guideline-based strategies for...
Community Clinic: Translating Data Into Action ─ Practical Strategies for Optimizing First-Line RCC Management 25.07.2025 15:15
CME credits: 0.25 Valid until: 25-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/Community-Clinic-Translating-Data-Into-Action-Practical-Strategies-for-Optimizing-First-Line-RCC-Management/35774/ Our experts, Drs. Robert Motzer and Elizabeth Plimack , discuss first-line treatment strategies for advanced renal cell carcinoma in a community clinic setting. Drawing from pivotal cli...
Maximizing Outcomes: Strategic Approaches in Metastatic CRC Treatment 24.07.2025 5:15
CME credits: 1.00 Valid until: 02-12-2026 Claim your CME credit at https://reachmd.com/programs/cme/maximizing-outcomes-strategic-approaches-in-metastatic-crc-treatment/36513/ This series provides expert perspectives on the management of metastatic colorectal cancer (mCRC), with a focus on the timing and methodology of molecular testing, targeted treatment combinations for BRAF-mutant mCRC, and th...
Case Consult: Current Standards and Emerging Directions in BRAF-Mutant mCRC Care 24.07.2025 5:00
CME credits: 1.00 Valid until: 02-12-2026 Claim your CME credit at https://reachmd.com/programs/cme/case-consult-current-standards-and-emerging-directions-in-braf-mutant-mcrc-care/36508/ This series provides expert perspectives on the management of metastatic colorectal cancer (mCRC), with a focus on the timing and methodology of molecular testing, targeted treatment combinations for BRAF-mutant m...
Advancing Molecular Therapies to First Line in BRAF-Mutated mCRC: Insights From Emerging Data 24.07.2025 5:15
CME credits: 1.00 Valid until: 02-12-2026 Claim your CME credit at https://reachmd.com/programs/cme/advancing-molecular-therapies-to-first-line-in-braf-mutated-mcrc-insights-from-emerging-data/36506/ This series provides expert perspectives on the management of metastatic colorectal cancer (mCRC), with a focus on the timing and methodology of molecular testing, targeted treatment combinations for...
Optimize Outcomes in CKD & T2D: A Practical Approach to Initiating and Monitoring Combination ns-MRA & SGLT2i Therapy 22.07.2025 14:00
CME credits: 0.25 Valid until: 22-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/optimize-outcomes-in-ckd-t2d-a-practical-approach-to-initiating-and-monitoring-combination-ns-mra-sglt2i-therapy/29904/ The CONFIDENCE trial shows that combining an SGLT2 inhibitor with finerenone cuts albuminuria by more than 50% in patients with chronic kidney disease and type 2 diabetes. In this...
Contrasting TROP2-Targeted ADCs in Breast Cancer Therapy 17.07.2025 31:30
CME credits: 0.50 Valid until: 17-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/contrasting-trop2-targeted-adcs-in-breast-cancer-therapy/33024/ This online chapterized CME activity features Drs. Kevin Kalinsky and Komal Jhaveri in a discussion on TROP2-targeted antibody-drug conjugates (ADCs) for metastatic breast cancer (mBC). The faculty describe the therapeutic role of TROP2...
How Do Patient Experiences and PAH Perspectives Vary Across Regions and Cultures Worldwide? 15.07.2025 4:45
CME credits: 1.00 Valid until: 15-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/how-do-patient-experiences-and-pah-perspectives-vary-across-regions-and-cultures-worldwide/33245/ Managing patients with pulmonary arterial hypertension, or PAH, can present certain challenges. PAH is a serious, progressive condition, and its effective management involves the consideration of severa...
PROMs: Role in Clinical Research and Contributions to PAH Patient Perspectives 15.07.2025 4:30
CME credits: 1.00 Valid until: 15-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/proms-role-in-clinical-research-and-contributions-to-pah-patient-perspectives/33244/ Managing patients with pulmonary arterial hypertension, or PAH, can present certain challenges. PAH is a serious, progressive condition, and its effective management involves the consideration of several factors to...
PROMs in Clinical Practice: Impacting Treatment Decisions 15.07.2025 5:45
CME credits: 1.00 Valid until: 15-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/proms-in-clinical-practice-impacting-treatment-decisions/33243/ Managing patients with pulmonary arterial hypertension, or PAH, can present certain challenges. PAH is a serious, progressive condition, and its effective management involves the consideration of several factors to meet treatment goals....
What Challenges and Triumphs Do Patients Face While Living With PAH? 15.07.2025 5:00
CME credits: 1.00 Valid until: 15-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/what-challenges-and-triumphs-do-patients-face-while-living-with-pah/33242/ Managing patients with pulmonary arterial hypertension, or PAH, can present certain challenges. PAH is a serious, progressive condition, and its effective management involves the consideration of several factors to meet treat...
A Comparison of PROMs and How to Use Them in Clinical Practice for PAH 15.07.2025 5:30
CME credits: 1.00 Valid until: 15-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/a-comparison-of-proms-and-how-to-use-them-in-clinical-practice-for-pah/33241/ Managing patients with pulmonary arterial hypertension, or PAH, can present certain challenges. PAH is a serious, progressive condition, and its effective management involves the consideration of several factors to meet tr...
Patient-Reported Outcome Measures (PROMs): Valuable Insights Into the Lived Experience of PAH 15.07.2025 5:00
CME credits: 1.00 Valid until: 15-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/patient-reported-outcome-measures-proms-valuable-insights-into-the-lived-experience-of-pah/33240/ Managing patients with pulmonary arterial hypertension, or PAH, can present certain challenges. PAH is a serious, progressive condition, and its effective management involves the consideration of severa...
Integrating Palliative Care in Pulmonary Hypertension 15.07.2025 5:00
CME credits: 1.00 Valid until: 15-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/integrating-palliative-care-in-pulmonary-hypertension/33239/ Managing patients with pulmonary arterial hypertension, or PAH, can present certain challenges. PAH is a serious, progressive condition, and its effective management involves the consideration of several factors to meet treatment goals. Th...
Aligning PAH Treatment Plans With Key Care Goals and Your Patients’ Priorities 15.07.2025 5:15
CME credits: 1.00 Valid until: 15-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/aligning-pah-treatment-plans-with-key-care-goals-and-your-patients-priorities/33238/ Managing patients with pulmonary arterial hypertension, or PAH, can present certain challenges. PAH is a serious, progressive condition, and its effective management involves the consideration of several factors to...
Managing Travel With PAH: Logistics, Medications, Oxygen, and Emergency Preparedness 15.07.2025 5:30
CME credits: 1.00 Valid until: 15-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/managing-travel-with-pah-logistics-medications-oxygen-and-emergency-preparedness/33237/ Managing patients with pulmonary arterial hypertension, or PAH, can present certain challenges. PAH is a serious, progressive condition, and its effective management involves the consideration of several factors...
The Latest Patient-Centered Recommendations From the 7th World Symposium on PH 15.07.2025 4:30
CME credits: 1.00 Valid until: 15-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/the-latest-patient-centered-recommendations-from-the-7th-world-symposium-on-ph/33236/ Managing patients with pulmonary arterial hypertension, or PAH, can present certain challenges. PAH is a serious, progressive condition, and its effective management involves the consideration of several factors to...
Chairperson’s Perspective: Precision in Practice: Advancing EGFR-Altered Metastatic NSCLC Through Guideline-Concordant, Case-Based Learning 14.07.2025 31:15
CME credits: 0.50 Valid until: 14-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/chairpersons-perspective-precision-in-practice-advancing-egfr-altered-metastatic-nsclc-through-guideline-concordant-case-based-learning/33808/ This 30-minute Chairperson’s Perspective program explores the evolving landscape of (epidermal growth factor receptor) EGFR -altered metastatic non–small cel...
Treatment of a Broader Population of Patients With DMD 14.07.2025 37:30
CME credits: 1.00 Valid until: 14-07-2026 Claim your CME credit at https://reachmd.com/programs/cme/treatment-of-a-broader-population-of-patients-with-dmd/33167/ By completing this activity, learners will gain the skills and confidence to determine therapeutic candidacy and conduct appropriate assessments for patients with Duchenne Muscular Dystrophy (DMD) across the age spectrum, including older...
Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics 25.04.2025 29:30
CME credits: 0.50 Claim your CME credit at https://reachmd.com/programs/cme/enhancing-diagnosis-treatment-and-outcomes-in-paroxysmal-nocturnal-hemoglobinuria-with-novel-oral-therapeutics/32762/ Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematologic disorder characterized by hemolytic anemia and associated with thrombophilia and bone marrow failure. Early and accurate diagnosis and classif...
Lignende podcasts
Replaio er ikke podcastudgiver; programmernes navne, coverbilleder og lyd tilhører deres ophavsmænd og distribueres via offentlige RSS-feeds.